Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan C Wagner

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2005
An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null miceMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Journal of Lipid Research|February 4, 2015
Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosisMohamad Navab, Arnab Chattopadhyay, Greg Hough, et al.
Journal of Lipid Research|February 5, 2013
A novel approach to oral apoA-I mimetic therapyArnab Chattopadhyay, Mohamad Navab, Greg Hough, et al.
Journal of Lipid Research|October 3, 2013
Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acidMohamad Navab, Greg Hough, Georgette M Buga, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2005
An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null miceMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Journal of Lipid Research|February 4, 2015
Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosisMohamad Navab, Arnab Chattopadhyay, Greg Hough, et al.
Journal of Lipid Research|February 5, 2013
A novel approach to oral apoA-I mimetic therapyArnab Chattopadhyay, Mohamad Navab, Greg Hough, et al.
Journal of Lipid Research|October 3, 2013
Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acidMohamad Navab, Greg Hough, Georgette M Buga, et al.
Pageof 2